Aynaud J M, Nguyen T D, Bottreau E, Brun A, Vannier P
J Gen Virol. 1985 Sep;66 ( Pt 9):1911-7. doi: 10.1099/0022-1317-66-9-1911.
Two transmissible gastroenteritis (TGE) virus mutants (188-SG and 152-SG) were obtained from a low-passage virus strain (D-52) by 188 and 152 cycles of stomach juice treatment and multiplication in cell culture. Compared to the high-passage Purdue-115 and the original D-52 strains, these mutants were more stable at pH 2.0, more resistant to pepsin and trypsin, and characterized by a small plaque phenotype. In vivo, the two mutants were not found to be virulent for 4-day-old piglets and sows after oral inoculation. To test induction of lactogenic immunity, the 188-SG mutant was administered orally to pregnant sows (6 or 7 weeks before parturition) followed by one intramuscular booster (1 week before parturition). After challenge with virulent TGE virus, piglet mortality 7 days after exposure was reduced (to 22%) as compared to the death rate in piglets from control sows (91%).
通过对低代次病毒株(D-52)进行188次和152次胃液处理及在细胞培养中传代,获得了两株传染性胃肠炎(TGE)病毒突变株(188-SG和152-SG)。与高代次的普渡-115株和原始的D-52株相比,这些突变株在pH 2.0时更稳定,对胃蛋白酶和胰蛋白酶更具抗性,且具有小蚀斑表型。在体内,口服接种后,未发现这两株突变株对4日龄仔猪和母猪具有致病性。为了测试泌乳免疫的诱导情况,在妊娠母猪分娩前6或7周口服给予188-SG突变株,然后在分娩前1周进行一次肌肉注射加强免疫。用强毒TGE病毒攻击后,与对照母猪所产仔猪91%的死亡率相比,暴露后7天仔猪死亡率降低(至22%)。